Question 1

What is the catalog number for OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89)?

Accepted Answer

The catalog number for OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89) is 249579.

Question 2

What sizes are available for OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89)?

Accepted Answer

OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89) is available in the following size(s): 200 µL.

Question 3

Is OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89) in stock?

Accepted Answer

OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 5

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 6

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

OBSCN (Obscurin, Cytoskeletal Calmodulin and Titin-Interacting RhoGEF, UNC89)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-CXCR5 Antibody Picoband® (Biotine Conjugate)

Anti-LAGE3 Antibody Picoband® (Biotine Conjugate)

MEMO1 Rabbit Polyclonal Antibody

Progesterone (6-5E-3F), CF647 conjugate, 0.1mg/mL

Human Nuclear Antigen (NM106), CF647 conjugate, 0.1mg/mL

Anti-GNG2 Antibody Picoband® (monoclonal, 7C13)